Diego Almanza
Impact in
-
- Urinary Bladder and Prostate Research
-
- Liver physiology and pathology
Papers in
-
- RNA modifications and cancer 2
- Connective Tissue Growth Factor Research 1
- Epigenetics and DNA Methylation 1
- Ubiquitin and proteasome pathways 1
-
- Lung Cancer Treatments and Mutations 1
- Prostate Cancer Diagnosis and Treatment 1
- Co-authors
- Jose Antonio Rodriguez-Nieves (3 shared papers)Jill A. Macoska (3 shared papers)Susan Patalano (2 shared papers)Mehrnaz Gharaee‐Kermani (2 shared papers)Todd Riley (2 shared papers)Candelaria Tejada-Tovar (1 shared paper)Joel W. Neal (1 shared paper)Young-Jun Jeon (1 shared paper)
- Journals
- Journal of Clinical Oncology (1 paper)PLoS ONE (1 paper)Cancer Research (1 paper)Digestive Diseases and Sciences (1 paper)Scientific Reports (1 paper)
- Partner nations
- United StatesColombia
In The Last Decade
Diego Almanza
4 papers receiving 62 citations
Peers
Comparison fields: 5 of 39
- Urology 8
- Hepatology 5
- Biological Psychiatry 1
- Immunology 8
- Cancer Research 5
Countries citing papers authored by Diego Almanza
This map shows the geographic impact of Diego Almanza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Almanza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Almanza more than expected).
Fields of papers citing papers by Diego Almanza
This network shows the impact of papers produced by Diego Almanza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Almanza. The network helps show where Diego Almanza may publish in the future.
Co-authors
The 25 scholars most cited alongside Diego Almanza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 30 | |
| 2 | 2018 | 12 | |
| 3 | 2017 | 12 | |
| 4 | 2018 | 8 | |
| 5 | 2020 | 0 | |
| 6 | 2024 | 0 | |
| 7 | RNA Seq Analysis of Non-Alcoholic Fatty Liver Disease (NAFLD) Induced by Metabolic Syndrome in a Mouse Model | 2016 | 0 |
About Diego Almanza
Diego Almanza is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Epidemiology, Endocrinology, Diabetes and Metabolism and Urology, having authored 7 papers that have together received 62 indexed citations. Recurring topics across this work include RNA modifications and cancer (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Connective Tissue Growth Factor Research (1 paper), Epigenetics and DNA Methylation (1 paper), Ubiquitin and proteasome pathways (1 paper), Lung Cancer Treatments and Mutations (1 paper), Urinary Bladder and Prostate Research (1 paper) and Prostate Cancer Diagnosis and Treatment (1 paper). The work is most often cited by research in Urology (8 citations), Hepatology (5 citations), Biological Psychiatry (1 citation), Immunology (8 citations) and Cancer Research (5 citations). Diego Almanza has collaborated with scholars based in United States and Colombia. Frequent co-authors include Jose Antonio Rodriguez-Nieves, Jill A. Macoska, Susan Patalano, Mehrnaz Gharaee‐Kermani, Todd Riley, Candelaria Tejada-Tovar, Joel W. Neal, Young-Jun Jeon, Heather A. Wakelee and Billy W. Loo. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE, Cancer Research, Digestive Diseases and Sciences and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.